TrimmTrack
Sign in

Johnson & Johnson (JNJ) valuation

Run six valuation models on Johnson & Johnson with live data: DCF, Reverse DCF, Graham number, Monte Carlo, scenarios and sum-of-the-parts (NAV).

JNJ
JNJ

Johnson & Johnson

JNJ · Healthcare

Current price

260,62 USD

You're trying every model for free, no account needed. Sign up to save your analyses →

Valuation

Market cap
$628.06B
PE (TTM | NTM | +1y)
30.20 | 21.18 | 21.18
Price / Sales
6.41
EV / EBITDA
18.77
Price / Book
7.39

Cash flow

FCF yield(7.01 / 260.62)
+2.69%
SBC-adjusted FCF yield
—
SBC impact
—

Margins & growth

Profit margin
+21.48%
Operating margin
+29.19%
Quarterly earnings (YoY)
-0.05%
Quarterly revenue (YoY)
+6.6%

Balance

Cash
$20.76B
Debt
$49.04B
Net position
-$28.28B

Dividend

Dividend yield
+2.06%
Payout ratio
+60.79%
Next payout
9/8/2026

Price (1 year)

+47.54%
$263.4

Revenue

estimate
Q2 23: $20.89BQ2 23Q3 23: $21.52BQ4 23: $21.35BQ4 23: $21.4BQ4 23Q1 24: $21.38BQ2 24: $22.45BQ3 24: $22.47BQ3 24Q4 24: $22.52BQ2 25: $23.74BQ3 25: $23.99BQ3 25Q4 25: $24.56BQ1 26: $24.06BQ2 26: $25.31BQ2 26Q3 26 · estimate: $25.19BQ3 26$25.31B

EBITDA

Q2 25: $8.74BQ2 25Q3 25: $9.52BQ3 25Q4 25: $7.19BQ4 25Q1 26: $8.27BQ1 26Q2 26: $8.99BQ2 26$9.52B

Net income

Q2 23: -$68MQ2 23Q3 23: $5.14BQ4 23: $26.03BQ4 23: $4.05BQ4 23Q1 24: $3.26BQ2 24: $4.69BQ3 24: $2.69BQ3 24Q4 24: $3.43BQ2 25: $5.54BQ3 25: $5.15BQ3 25Q4 25: $5.12BQ1 26: $5.24BQ2 26: $5.53BQ2 26$26.03B

Free cash flow

Q2 23: $2.39BQ2 23Q1 24: $2.85BQ2 25: $2.48BQ2 25Q3 25: $8BQ4 25: $5.47BQ4 25Q1 26: $1.47BQ2 26: $7.3BQ2 26$8B

EPS

estimate
Q2 23: -0.03Q2 23Q3 23: 1.96Q4 23: 10.21Q4 23: 1.67Q4 23Q1 24: 1.34Q2 24: 1.93Q3 24: 1.11Q3 24Q4 24: 1.41Q2 25: 2.29Q3 25: 2.12Q3 25Q4 25: 2.10Q1 26: 2.14Q2 26: 2.27Q2 26Q3 26 · estimate: 2.42Q3 2610.21

Cash & debt

CashDebt
Q2 23 · Cash: $19.17BQ2 23Q3 23 · Cash: $21.18BQ4 23 · Cash: $19.73BQ4 23 · Cash: $21.86BQ4 23Q1 24 · Cash: $25.47BQ2 24 · Cash: $24.88BQ3 24 · Cash: $19.98BQ3 24Q4 24 · Cash: $24.11BQ2 25 · Cash: $18.58BQ2 25 · Debt: $50.76BQ3 25 · Cash: $18.23BQ3 25 · Debt: $45.8BQ3 25Q4 25 · Cash: $19.71BQ4 25 · Debt: $47.93BQ1 26 · Cash: $21.69BQ1 26 · Debt: $54.99BQ2 26 · Cash: $20.42BQ2 26 · Debt: $49.04BQ2 26$54.99B

Return of capital

DividendsBuybacks
Q2 23 · Buybacks: $3.54BQ2 23Q1 24 · Buybacks: $1.48BQ2 25 · Dividends: $3.13BQ2 25Q3 25 · Dividends: $3.13BQ3 25 · Buybacks: $1.9BQ4 25 · Dividends: $3.13BQ4 25 · Buybacks: $1.92BQ4 25Q1 26 · Dividends: $3.13BQ1 26 · Buybacks: $4.03BQ2 26 · Dividends: $3.23BQ2 26 · Buybacks: $221MQ2 26$7.16B

Shares outstanding

Q2 23: 2.6BQ2 23Q3 23: 2.6BQ4 23: 2.41BQ1 24: 2.41BQ1 24Q2 24: 2.41BQ3 24: 2.41BQ4 24: 2.41BQ4 24Q1 25: 2.41BQ2 25: 2.41BQ3 25: 2.41BQ3 25Q4 25: 2.41BQ1 26: 2.41BQ1 26: 2.41BQ2 26: 2.41BQ2 262.6B

Stock-based compensation

Q2 23: $306MQ2 23Q1 24: $302MQ2 25: $410MQ2 25Q3 25: $347MQ4 25: $309MQ4 25Q1 26: $300MQ2 26: $458MQ2 26$458M

Operating expenses

R&DSG&A
Q2 23 · SG&A: $4.91BQ2 23Q3 23 · SG&A: $5.4BQ4 23 · SG&A: $5.4BQ4 23 · SG&A: $5.81BQ4 23Q1 24 · SG&A: $5.26BQ2 24 · SG&A: $5.68BQ3 24 · SG&A: $5.48BQ3 24Q4 24 · SG&A: $6.45BQ2 25 · R&D: $3.52BQ2 25 · SG&A: $5.89BQ3 25 · R&D: $3.67BQ3 25 · SG&A: $5.92BQ3 25Q4 25 · R&D: $4.25BQ4 25 · SG&A: $6.75BQ1 26 · R&D: $3.53BQ1 26 · SG&A: $6.03BQ2 26 · R&D: $3.65BQ2 26 · SG&A: $6.43BQ2 26$11.01B

Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.

Other comparisons

Johnson & Johnson vs PfizerUnitedHealth vs Johnson & Johnson

Popular companies

AppleNvidiaTeslaMicrosoftAmazonAlphabet (Google)Meta PlatformsNetflixAMDPalantirBerkshire HathawayJPMorgan ChaseVisaMastercardWalt DisneyCoca-ColaPepsiCoMcDonald'sNikeStarbucksIntelBroadcomQualcommOracleSalesforceAdobePayPalUberAirbnbCoinbase